Reciprocal Amplification of Glial Senescence and α-synucleinopathy in Parkinson’s Disease: The Therapeutic Potential Promise of Senolytics | Chapter 8 | Disease and Health Research: New Insights Vol. 11

Parkinson’s disease (PD) is the most common movement disorder and the second most prevalent neurodegenerative disease after Alzheimer’s disease. Despite decades of research, there is still no cure for PD and the complicated intricacies of the pathology are still being worked out. A hallmark of the disease is the abnormal formation of toxic fibrils of α-synuclein, which then clump into Lewy body aggregates. Lewy bodies rob neurons and glia of their function, eventually leading to their death. This chapter presents a current perspective on the interactive roles that α-synuclein and glial senescence have in PD. The self-amplifying and cyclical nature of oxidative stress, neuroinflammation, α-synucleinopathy, neuroglial senescence, neuroglial chronic activation and neurodegeneration will be discussed. This progressive, degenerative cycle can be interrupted by using senolytics to specifically target and remove senescent cells. Therefore, the compelling role that senolytics could play as a therapeutic avenue for PD will also be explored and encouraged.

 

Author (s) Details

 

Audrey Gibbs
Department of Biology and Biotechnology, School of Science and Technology, Endicott College, Beverly, MA, USA.

 

Sean J. Miller
Pluripotent Diagnostics Corp. (PDx), Molecular Medicine Research Institute, Sunnyvale, CA, USA.

 

Robert Logan
Department of Biology and Biotechnology, School of Science and Technology, Endicott College, Beverly, MA, USA.

 

Please see the book here:- https://doi.org/10.9734/bpi/dhrni/v11/3106

Glial Cell-Targeted Treatments for Bipolar Disorder: A Systematic Review of Available Data and Clinical Perspectives | Chapter 6 | Novel Research Aspects in Medicine and Medical Science Vol. 2

 Bipolar disorder poses meaningful challenges to the mental health society, and effective situation strategies are crucial in directing this complex condition. This paper presents a comprehensive orderly review of treatment approaches for bipolar disorder, accompanying a specific devote effort to something synthesizing evidence from treatment directions and clinical trials. A orderly search was conducted utilizing Google Scholar, yielding 375 relevant documents, during the ending from June 1, 2022, to August 30, 2022.The primary objective of this study search out provide an revised and rigorous evaluation of the existent treatment guidelines and dispassionate trial evidence for bipolar disorder. By checking a wide range of interventions, this review aims to offer clinicians and investigators valuable insights into evidence-located practices for the management of this disorder.The verdicts of this review reveal essential situation modalities for manic-depressive illness. Lithium emerges as a critical pharmacological mediation for controlling and lessening severe mood adventures. Additionally, olanzapine demonstrates productiveness in managing acute crazy or mixed episodes of manic-depressive illness. Moreover, Cariprazine shows promise in achieving better influence or remission outcomes.  Lurasidone is emphasize for its potential in reconstructing cognitive performance between individuals accompanying bipolar disorder.Furthermore, this study underscores the significance of addressing co-morbid environments in bipolar disorder administration. For instance, quetiapine is identified as an effective situation for improving sleep condition and co-morbid anxiety. The consolidation of carbamazepine and lithium emerges as a favored approach in managing psychotic madness with co-morbidity. Adjunctive olanzapine or lamotrigine is urged for treating co-nasty anxiety, while mood stabilizers confirm beneficial in calling co-morbid bulimia. Moreover, fatigue situation considerations suggest the exercise of a dawn simulator.In agreements of dietary recommendations, the review stresses the significance of adopting a healthful diet. Probiotics intake and attention to the balance of oily acids are suggested to support overall prosperity in patients with manic-depressive illness.In conclusion, this systematic review provides inclusive insights into evidence-located treatment options for manic-depressive illness. By evaluating the influence of various interventions, it offers clinicians and scientists valuable guidelines to improve the management of bipolar disorder efficiently. The findings of this study focal point the critical function of treatment guidelines and dispassionate trials in numbering the knowledge base and improving effects for individuals endure bipolar disorder.

Author(s) Details:

Julia Wang,
Lumiere Academy, Shanghai, China.

Please see the link here: https://stm.bookpi.org/NRAMMS-V2/article/view/11802

Role of Microglia in the Regulation of Neural Stem Cells in the Healthy and Injured Brain | Chapter 8 | Research Developments in Medicine and Medical Science Vol. 9

 This member is aimed to describe by virtue of what microglial cells organize neural stem cells (NSCs), making importance on bran-hurt conditions without set aside the healthy intelligence. Microglia constitute the main immune component of the CNS and, in addition to astrocytes, are the first line of defense against brain harm, infections, or added aversive stimuli. In common conditions, microglia help maintain brain homeostasis, but their function is not restricted to a defensive duty, and they participate in synaptic pruning, manage neuronal apoptosis, depurate container debris, and promote myelination. An supplementary function of microglial cells is the regulation of stem container niches: the ventricular-subventricular district (V-SVZ) and the subgranular zone (SGZ) of the hippocampus. Both niches create new neurons in the adult brain and their affecting animate nerve organs progenitors are in close contact with microglia, which appear to regulate distinction and self-renewal of adult neural stem containers (NSCs).

Author(s) Details:

Eduardo Lira-Diaz,
Departamento de Nanomateriales, Centro Conjunto de Invcestigación en Química Sustentable, UAEMex-UNAM. Toluca de Lerdo, Estado de México, México and Facultad de Medicina, Universidad Autónoma del Estado de Morelos. Cuernavaca, Morelos, México.

Juan J. Acevedo-Fernandez,
Facultad de Medicina, Universidad Autónoma del Estado de Morelos. Cuernavaca, Morelos, México.

Alma Y. Galvez-Contreras,
Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, México.

Raul A. Morales-Luckie,
Departamento de Nanomateriales, Centro Conjunto de Invcestigación en Química Sustentable, UAEMex-UNAM. Toluca de Lerdo, Estado de México, México.

Oscar Gonzalez-Perez,
Laboraorio de Neurociencias, Facultad de Psicología, Universidad de Colima. Colima, Colima. México.

Please see the link here: https://stm.bookpi.org/RDMMS-V9/article/view/10359